Sulfamethoxazole S045-50G

产品介绍

Sulfamethoxazole is a bacteriostatic sulfonamide antibiotic that was first synthesized in 1957 by researchers at Shionogi Inc. in Japan and launched as Sinomin.  Sulfamethoxazole has broad-spectrum antimicrobial activity and is normally given in combination with Trimethoprim, a dihydrofolate reductase inhibitor, which inhibits the reduction of dihydrofolic acid to tetrahydrofolic acid. Studies have shown that bacterial resistance develops more slowly with the combination of the two drugs than with either Trimethoprim or Sulfamethoxazole alone.

Sulfamethoxazole is one of the compounds that is being screened for potential utility for COVID-19.